Trade Valneva SE - VLA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.022079% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.000143% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5% | ||||||||
Stock exchange | France | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Valneva SE ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 5.21 |
Open* | 5.24 |
1-Year Change* | -19.38% |
Day's Range* | 5.22 - 5.33 |
52 wk Range | 3.95-7.85 |
Average Volume (10 days) | 754.22K |
Average Volume (3 months) | 6.80M |
Market Cap | 764.21M |
P/E Ratio | -100.00K |
Shares Outstanding | 138.77M |
Revenue | 223.22M |
EPS | -0.96 |
Dividend (Yield %) | N/A |
Beta | 0.57 |
Next Earnings Date | Mar 21, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 29, 2023 | 5.26 | 0.05 | 0.96% | 5.21 | 5.34 | 5.21 |
Nov 28, 2023 | 5.21 | 0.07 | 1.36% | 5.14 | 5.24 | 5.09 |
Nov 27, 2023 | 5.17 | -0.03 | -0.58% | 5.20 | 5.41 | 5.15 |
Nov 24, 2023 | 5.20 | -0.09 | -1.70% | 5.29 | 5.31 | 5.16 |
Nov 23, 2023 | 5.35 | -0.12 | -2.19% | 5.47 | 5.47 | 5.10 |
Nov 22, 2023 | 5.48 | -0.11 | -1.97% | 5.59 | 5.60 | 5.28 |
Nov 21, 2023 | 5.61 | -0.21 | -3.61% | 5.82 | 5.84 | 5.59 |
Nov 20, 2023 | 5.83 | 0.19 | 3.37% | 5.64 | 5.88 | 5.59 |
Nov 17, 2023 | 5.63 | 0.00 | 0.00% | 5.63 | 5.78 | 5.55 |
Nov 16, 2023 | 5.66 | -0.04 | -0.70% | 5.70 | 5.77 | 5.63 |
Nov 15, 2023 | 5.77 | -0.13 | -2.20% | 5.90 | 5.99 | 5.67 |
Nov 14, 2023 | 5.85 | -0.29 | -4.72% | 6.14 | 6.14 | 5.68 |
Nov 13, 2023 | 6.23 | -0.22 | -3.41% | 6.45 | 6.46 | 6.23 |
Nov 10, 2023 | 6.32 | -0.63 | -9.06% | 6.95 | 7.01 | 6.24 |
Nov 9, 2023 | 6.25 | 0.30 | 5.04% | 5.95 | 6.26 | 5.70 |
Nov 8, 2023 | 5.99 | 0.09 | 1.53% | 5.90 | 6.19 | 5.65 |
Nov 7, 2023 | 5.85 | 0.31 | 5.60% | 5.54 | 5.93 | 5.54 |
Nov 6, 2023 | 5.75 | -0.03 | -0.52% | 5.78 | 5.90 | 5.73 |
Nov 3, 2023 | 5.89 | 0.43 | 7.88% | 5.46 | 5.92 | 5.46 |
Nov 2, 2023 | 5.62 | 0.08 | 1.44% | 5.54 | 5.79 | 5.42 |
Valneva SE Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, March 21, 2024 | ||
Time (UTC) 07:30 | Country FR
| Event Full Year 2023 Valneva SE Earnings Release Full Year 2023 Valneva SE Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 361.303 | 348.086 | 110.321 | 126.196 | 113.035 |
Revenue | 361.303 | 348.086 | 110.321 | 126.196 | 113.035 |
Cost of Revenue, Total | 324.441 | 182.22 | 46.902 | 49.968 | 44.448 |
Gross Profit | 36.862 | 165.866 | 63.419 | 76.228 | 68.587 |
Total Operating Expense | 474.746 | 409.476 | 165.441 | 127.007 | 106.774 |
Selling/General/Admin. Expenses, Total | 56.499 | 70.761 | 45.171 | 42.277 | 37.84 |
Research & Development | 101.322 | 168.583 | 61.354 | 36.783 | 24.291 |
Depreciation / Amortization | 4.9 | 5.4 | 4.9 | 4.464 | 4.331 |
Unusual Expense (Income) | 0.038 | 5.742 | 26.41 | 0.092 | 0.007 |
Other Operating Expenses, Total | -12.454 | -23.23 | -19.296 | -6.577 | -4.143 |
Operating Income | -113.443 | -61.39 | -55.12 | -0.811 | 6.261 |
Interest Income (Expense), Net Non-Operating | -31.108 | -8.281 | -10.182 | -0.059 | -2.909 |
Other, Net | -0.264 | -0.308 | -0.001 | ||
Net Income Before Taxes | -144.815 | -69.979 | -65.302 | -0.87 | 3.351 |
Net Income After Taxes | -143.279 | -73.425 | -64.393 | -1.744 | 3.263 |
Net Income Before Extra. Items | -143.279 | -73.425 | -64.393 | -1.744 | 3.263 |
Net Income | -143.279 | -73.425 | -64.393 | -1.744 | 3.263 |
Income Available to Common Excl. Extra. Items | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
Income Available to Common Incl. Extra. Items | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
Diluted Net Income | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
Diluted Weighted Average Shares | 115.474 | 97.6193 | 90.7572 | 91.7443 | 81.6002 |
Diluted EPS Excluding Extraordinary Items | -1.24079 | -0.75216 | -0.70951 | -0.01901 | 0.04 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Diluted Normalized EPS | -1.10971 | -0.71392 | -0.51936 | -0.01836 | 0.04008 |
Total Adjustments to Net Income | 0.001 | ||||
Dilution Adjustment | 0 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 73.743 | 33.508 | 268.079 | 156.678 | 93.224 |
Revenue | 73.743 | 33.508 | 268.079 | 156.678 | 93.224 |
Cost of Revenue, Total | 53.838 | 20.48 | 152.962 | 31.247 | 171.479 |
Gross Profit | 19.905 | 13.028 | 115.117 | 125.431 | -78.255 |
Total Operating Expense | 108.709 | 50.082 | 231.112 | 63.361 | 243.634 |
Selling/General/Admin. Expenses, Total | 43.261 | 19.024 | 33.704 | 12.488 | 24.095 |
Research & Development | 25.978 | 14.065 | 53.039 | 23.502 | 51.883 |
Other Operating Expenses, Total | -14.441 | -3.487 | -8.585 | -3.876 | -3.869 |
Operating Income | -34.966 | -16.574 | 36.967 | 93.317 | -150.41 |
Interest Income (Expense), Net Non-Operating | -3.836 | -1.673 | -12.531 | -21.007 | -18.577 |
Other, Net | -0.022 | -0.029 | -0.235 | ||
Net Income Before Taxes | -38.824 | -18.247 | 24.407 | 72.31 | -169.222 |
Net Income After Taxes | -35.046 | -18.127 | 28.214 | 72.418 | -171.493 |
Net Income Before Extra. Items | -35.046 | -18.127 | 28.214 | 72.418 | -171.493 |
Net Income | -35.046 | -18.127 | 28.214 | 72.418 | -171.493 |
Income Available to Common Excl. Extra. Items | -35.046 | -18.127 | 28.214 | 72.418 | -171.493 |
Income Available to Common Incl. Extra. Items | -35.046 | -18.127 | 28.214 | 72.418 | -171.493 |
Diluted Net Income | -35.046 | -18.127 | 28.214 | 72.418 | -171.493 |
Diluted Weighted Average Shares | 140.184 | 139.438 | 122.408 | 105.991 | 108.54 |
Diluted EPS Excluding Extraordinary Items | -0.25 | -0.13 | 0.23049 | 0.68325 | -1.58 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.25842 | -0.13 | 0.33638 | 0.68325 | -1.55996 |
Unusual Expense (Income) | 0.073 | -0.008 | 0.046 | ||
Total Adjustments to Net Income |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 424.66 | 585.832 | 308.427 | 129.162 | 125.972 |
Cash and Short Term Investments | 286.532 | 346.642 | 204.394 | 64.439 | 77.084 |
Cash | 286.533 | 346.642 | 173.109 | 39.439 | 57.085 |
Cash & Equivalents | -0.001 | -0.001 | |||
Short Term Investments | 31.285 | 25 | 20 | ||
Total Receivables, Net | 23.912 | 44.013 | 19.232 | 24.03 | 11.259 |
Accounts Receivable - Trade, Net | 23.912 | 44.013 | 19.232 | 24.03 | 11.259 |
Total Inventory | 35.104 | 124.098 | 26.933 | 25.772 | 22.727 |
Other Current Assets, Total | 79.112 | 71.079 | 57.868 | 14.921 | 14.902 |
Total Assets | 621.344 | 817.352 | 449.164 | 264.723 | 229.907 |
Property/Plant/Equipment, Total - Net | 154.038 | 173.83 | 78.153 | 69.337 | 37.997 |
Property/Plant/Equipment, Total - Gross | 221.187 | 215.283 | 111.31 | 100.5 | 75.012 |
Accumulated Depreciation, Total | -67.148 | -41.453 | -33.156 | -31.163 | -37.015 |
Intangibles, Net | 28.711 | 32.7 | 35.409 | 41.813 | 44.891 |
Other Long Term Assets, Total | 13.935 | 22.866 | 25.045 | 22.148 | 19.925 |
Total Current Liabilities | 277.392 | 368.979 | 175.87 | 41.3 | 42.944 |
Accounts Payable | 14.505 | 16.035 | 24.898 | 8.868 | 9.175 |
Accrued Expenses | 42.724 | 69.333 | 24.479 | 18.323 | 12.793 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 36.991 | 10.242 | 9.684 | 4.307 | 17.529 |
Other Current Liabilities, Total | 183.172 | 273.369 | 116.809 | 9.802 | 3.447 |
Total Liabilities | 401.547 | 646.771 | 371.742 | 129.57 | 86.72 |
Total Long Term Debt | 115.39 | 104.413 | 95.767 | 80.909 | 40.07 |
Long Term Debt | 87.227 | 50.726 | 46.375 | 24.317 | 14.272 |
Capital Lease Obligations | 28.163 | 53.687 | 49.392 | 56.592 | 25.798 |
Deferred Income Tax | 0.694 | 1.29 | 0.412 | ||
Other Liabilities, Total | 8.071 | 172.089 | 99.693 | 7.361 | 3.706 |
Total Equity | 219.797 | 170.581 | 77.422 | 135.153 | 143.187 |
Common Stock | 20.755 | 15.786 | 13.646 | 13.642 | 13.638 |
Additional Paid-In Capital | 594.043 | 409.258 | 244.984 | 297.732 | 297.72 |
Retained Earnings (Accumulated Deficit) | -389.315 | -248.671 | -177.835 | -170.272 | -161.559 |
Treasury Stock - Common | -0.645 | -0.645 | -0.898 | -1.112 | -1.133 |
Other Equity, Total | -5.041 | -5.147 | -2.475 | -4.837 | -5.479 |
Total Liabilities & Shareholders’ Equity | 621.344 | 817.352 | 449.164 | 264.723 | 229.907 |
Total Common Shares Outstanding | 138.223 | 105.115 | 90.8242 | 90.8195 | 90.7935 |
Total Preferred Shares Outstanding | 0.02051 | 17.8367 | 17.8367 | 17.8367 | 17.8367 |
Long Term Investments | 0 | 2.124 | 2.13 | 2.263 | 1.122 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 320.653 | 341.48 | 389.329 | 424.66 | 476.535 |
Cash and Short Term Investments | 171.253 | 204.411 | 254.485 | 286.532 | 261.042 |
Cash & Equivalents | 171.253 | 204.411 | 254.485 | -0.001 | 261.042 |
Total Receivables, Net | 44.346 | 33.669 | 27.018 | 23.912 | 57.732 |
Accounts Receivable - Trade, Net | 44.346 | 33.669 | 27.018 | 23.912 | 57.732 |
Total Inventory | 38 | 33.353 | 38.999 | 35.104 | 96.462 |
Other Current Assets, Total | 67.054 | 70.047 | 68.827 | 79.112 | 61.299 |
Total Assets | 520.539 | 542.571 | 590 | 621.344 | 698.083 |
Property/Plant/Equipment, Total - Net | 156.133 | 156.1 | 158.039 | 154.038 | 170.659 |
Intangibles, Net | 26.341 | 27.125 | 27.896 | 28.711 | 29.652 |
Long Term Investments | 0 | 0 | |||
Other Long Term Assets, Total | 17.412 | 17.866 | 14.736 | 13.935 | 21.237 |
Total Current Liabilities | 218.151 | 241.043 | 263.26 | 277.392 | 374.211 |
Payable/Accrued | 94.241 | 33.52 | 41.491 | 74.973 | |
Accrued Expenses | 14.496 | 41.524 | 15.875 | 15.738 | 16.036 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 59.605 | 47.134 | 39.944 | 36.991 | 15.612 |
Other Current Liabilities, Total | 49.809 | 108.249 | 173.921 | 183.172 | 267.59 |
Total Liabilities | 363.018 | 351.864 | 385.217 | 401.547 | 533.1 |
Total Long Term Debt | 134.898 | 102.098 | 112.784 | 115.39 | 146.007 |
Long Term Debt | 107.047 | 74.216 | 83.228 | 87.227 | 93.364 |
Capital Lease Obligations | 27.851 | 27.882 | 29.556 | 28.163 | 52.643 |
Deferred Income Tax | 2.22 | 0.971 | 1.057 | 0.694 | 1.784 |
Other Liabilities, Total | 7.749 | 7.752 | 8.116 | 8.071 | 11.098 |
Total Equity | 157.521 | 190.707 | 204.783 | 219.797 | 164.983 |
Common Stock | 20.837 | 20.834 | 20.752 | 20.755 | 17.603 |
Additional Paid-In Capital | 594.003 | 593.96 | 594.043 | 594.043 | 501.638 |
Retained Earnings (Accumulated Deficit) | -457.319 | -424.088 | -410.011 | -389.315 | -354.258 |
Other Equity, Total | 0.001 | -0.001 | -5.041 | ||
Total Liabilities & Shareholders’ Equity | 520.539 | 542.571 | 590 | 621.344 | 698.083 |
Total Common Shares Outstanding | 138.772 | 138.772 | 138.223 | 138.223 | 117.276 |
Total Preferred Shares Outstanding | 0.02051 | 0.02051 | 0.02051 | ||
Cash | 286.533 | ||||
Short Term Investments | |||||
Treasury Stock - Common | -0.645 | ||||
Accounts Payable | 44.136 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
Cash From Operating Activities | -242.445 | 76.945 | 137.779 | 5.529 | 16.306 |
Cash From Operating Activities | 21.036 | 14.281 | 9.799 | 8.532 | 6.828 |
Non-Cash Items | -126.058 | 101.55 | 116.613 | 7.769 | 3.534 |
Cash Taxes Paid | 0.154 | 1.631 | 2.021 | 2.346 | 1.273 |
Cash Interest Paid | 9.211 | 8.417 | 4.711 | 2.621 | 4.165 |
Changes in Working Capital | 5.856 | 34.539 | 75.76 | -9.028 | 2.68 |
Cash From Investing Activities | -29.054 | -93.116 | -19.34 | -10.685 | -2.917 |
Capital Expenditures | -29.322 | -93.171 | -19.471 | -10.884 | -3.171 |
Other Investing Cash Flow Items, Total | 0.268 | 0.055 | 0.131 | 0.199 | 0.254 |
Cash From Financing Activities | 215.116 | 154.504 | 21.74 | -7.696 | 30.945 |
Financing Cash Flow Items | -9.211 | -8.417 | -4.71 | -2.621 | -4.165 |
Issuance (Retirement) of Stock, Net | 189.837 | 166.823 | 0.29 | -2.463 | 49.263 |
Issuance (Retirement) of Debt, Net | 34.49 | -3.902 | 26.16 | -2.612 | -14.153 |
Foreign Exchange Effects | -0.828 | 3.96 | -0.183 | 0.207 | -0.795 |
Net Change in Cash | -57.211 | 142.293 | 139.996 | -12.645 | 43.539 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -18.127 | -143.279 | -99.075 | -171.493 | -26.041 |
Cash From Operating Activities | -24.326 | -242.445 | -186.562 | -100.18 | -26.806 |
Non-Cash Items | 8.438 | -126.058 | 17.784 | -5.481 | -6.922 |
Cash Taxes Paid | 0.433 | 0.154 | 1.082 | 0.818 | 0.318 |
Cash Interest Paid | 2.689 | 9.211 | 6.544 | 4.054 | 1.909 |
Changes in Working Capital | -14.637 | 5.856 | -105.271 | 65.641 | 6.157 |
Cash From Investing Activities | -3.561 | -29.054 | -22.483 | -15.994 | -9.447 |
Capital Expenditures | -3.814 | -29.322 | -22.541 | -16.028 | -9.461 |
Other Investing Cash Flow Items, Total | 0.253 | 0.268 | 0.058 | 0.034 | 0.014 |
Cash From Financing Activities | -3.816 | 215.116 | 121.631 | 105.006 | 0.982 |
Financing Cash Flow Items | -2.689 | -9.211 | -6.544 | -4.054 | -1.909 |
Issuance (Retirement) of Stock, Net | -0.194 | 189.837 | 93.998 | 94.308 | 3.726 |
Issuance (Retirement) of Debt, Net | -0.933 | 34.49 | 34.177 | 14.752 | -0.835 |
Foreign Exchange Effects | -0.344 | -0.828 | 1.814 | 0.751 | -0.107 |
Net Change in Cash | -32.047 | -57.211 | -85.6 | -10.417 | -35.378 |
Cash From Operating Activities | 21.036 | 11.153 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Grimaud Family | Other Insider Investor | 9.51 | 13209067 | 0 | 2023-07-31 | LOW |
Bpifrance Participations S.A. | Sovereign Wealth Fund | 9.2164 | 12801207 | 1184386 | 2023-06-20 | LOW |
CDC Entreprises Valeurs Moyennes | Investment Advisor | 8.56 | 11889549 | -875049 | 2023-07-31 | LOW |
Pfizer Inc | Corporation | 6.87 | 9542196 | -13890 | 2023-07-31 | LOW |
Deep Track Capital LP | Hedge Fund | 6.55 | 9097727 | -1416746 | 2023-07-31 | MED |
Polar Capital LLP | Investment Advisor/Hedge Fund | 3.6343 | 5047974 | -37561 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.0466 | 2842624 | 1025 | 2023-09-30 | LOW |
Medical Strategy GmbH | Investment Advisor | 1.5495 | 2152225 | 0 | 2023-05-31 | MED |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.4732 | 2046160 | 2046160 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2716 | 1766167 | 27679 | 2023-09-30 | LOW |
Valneva SE Employees | Corporation | 0.92 | 1277849 | 0 | 2023-07-31 | |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.2977 | 413482 | -5274 | 2023-09-30 | LOW |
HSBC Global Asset Management (France) S.A. | Investment Advisor | 0.2212 | 307237 | -40571 | 2022-12-31 | LOW |
General American Investors Company, Inc. | Investment Advisor | 0.1607 | 223201 | 0 | 2023-06-30 | LOW |
Fubon Asset Management Company Ltd. | Investment Advisor | 0.148 | 205513 | -4390 | 2023-07-31 | MED |
ÖKOWORLD LUX S.A. | Investment Advisor | 0.144 | 200000 | 200000 | 2022-06-30 | LOW |
AXA Investment Managers Paris | Investment Advisor/Hedge Fund | 0.1417 | 196769 | 0 | 2023-08-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1395 | 193740 | -372 | 2023-09-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.1379 | 191558 | 0 | 2023-09-30 | LOW |
La Française AM | Investment Advisor | 0.126 | 175000 | 25000 | 2023-06-30 | MED |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Valneva SE Company profile
About Valneva SE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Financial summary
BRIEF: For the six months ended 30 June 2021, Valneva SE revenues decreased 1% to EUR47.5M. Net loss applicable to common stockholders increased from EUR25.6M to EUR86.4M. Revenues reflect Commercialized Vaccines segment decrease of 22% to EUR31.8M, Canada segment decrease of 75% to EUR2M, United Kingdom segment decrease of 75% to EUR1.1M, Europe excluding France segment decrease of 42% to EUR4.2M.
Equity composition
07/2010, Rights Issue, 2 new shares for every 5 shares held @ EUR 5.06 (Factor: 1.12817). 6/2013, Rights Issue, 5 new shares for every 13 shares held @ EUR2.65 (Factor: 1.11881). 1/2015, Rights Issue, 11 new shares for every 34 shares held @ EUR2.47 (Factor: 1.10896).
Industry: | Biotechnology & Medical Research (NEC) |
6 rue Alain Bombard
SAINT-HERBLAIN
PAYS DE LA LOIRE 44800
FR
Income Statement
- Annual
- Quarterly
News

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023
Gold Rises as Traders price-in Fed Rate Cuts
Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.
13:17, 20 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com